secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revolution Medicines, Inc. (RVMD)
CIK:        0001628171
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0001193125-22-177651
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Revolution Medicines stockholders elect directors, ratify auditor, approve say-on-pay at annual meeting
--------------------------------------------------------------------------------

- Elected three Class II directors: Sushil Patel, Eric Schmidt, Thilo Schroeder with substantial support.
- Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2022 (62.1M for, 6,377 against).
- Advisory approval of named executive officer compensation (53.4M for, 4.6M against, broker non-votes 4.1M).
- Advisory vote favored holding future say-on-pay votes annually (57.8M for one year); company will adopt annual frequency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628171/000119312522177651/0001193125-22-177651-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628171/000119312522177651/d370111d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-177651

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer